CHONDROFILLER Trademark

Trademark Overview

On Wednesday, January 8, 2020, a trademark application was filed for CHONDROFILLER with the United States Patent and Trademark Office. The USPTO has given the CHONDROFILLER trademark a serial number of 79280035. The federal status of this trademark filing is REGISTERED as of Tuesday, May 18, 2021. This trademark is owned by Meidrix Biomedicals GmbH. The CHONDROFILLER trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals and veterinary preparations, in particular collagen-based preparations and implants comprising biological material for treating tissue and joint damage
chondrofiller

General Information

Serial Number79280035
Word MarkCHONDROFILLER
Filing DateWednesday, January 8, 2020
Status700 - REGISTERED
Status DateTuesday, May 18, 2021
Registration Number6350554
Registration DateTuesday, May 18, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Goods and ServicesPharmaceuticals and veterinary preparations, in particular collagen-based preparations and implants comprising biological material for treating tissue and joint damage

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 6, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeidrix Biomedicals GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameMeidrix Biomedicals GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDE
Party NameMeidrix Biomedicals GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDE

Trademark Events

Event DateEvent Description
Monday, September 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, August 30, 2021FINAL DISPOSITION NOTICE SENT TO IB
Monday, August 30, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 18, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 18, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Monday, March 1, 2021NOTIFICATION PROCESSED BY IB
Wednesday, February 10, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 10, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 25, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 25, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 25, 2021ASSIGNED TO LIE
Tuesday, October 13, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 1, 2020REFUSAL PROCESSED BY IB
Tuesday, April 14, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, April 14, 2020REFUSAL PROCESSED BY MPU
Friday, March 27, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, March 26, 2020NON-FINAL ACTION WRITTEN
Thursday, March 26, 2020ASSIGNED TO EXAMINER
Tuesday, March 10, 2020APPLICATION FILING RECEIPT MAILED
Friday, March 6, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 5, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

chondrofiller preparations treating material tissue joint damage biological implants particular veterinary